Suppression of Drug Resistance in Dengue Virus

Dengue virus is a major human pathogen responsible for 400 million infections yearly. As with other RNA viruses, daunting challenges to antiviral design exist due to the high error rates of RNA-dependent RNA synthesis. Indeed, treatment of dengue virus infection with a nucleoside analog resulted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateo, Roberto, Nagamine, Claude M., Kirkegaard, Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Microbiology 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701834/
https://www.ncbi.nlm.nih.gov/pubmed/26670386
http://dx.doi.org/10.1128/mBio.01960-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701834/
https://www.ncbi.nlm.nih.gov/pubmed/26670386
http://dx.doi.org/10.1128/mBio.01960-15

Ejemplares similares